Literature DB >> 27784058

Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium.

Cecilia G Ethun1, Lauren M Postlewait1, Nina Le1, Timothy M Pawlik2, Stefan Buettner3, George Poultsides4, Thuy Tran4, Kamran Idrees5, Chelsea A Isom5, Ryan C Fields6, Linda X Jin6, Sharon M Weber7, Ahmed Salem7, Robert C G Martin8, Charles Scoggins8, Perry Shen9, Harveshp D Mogal9, Carl Schmidt10, Eliza Beal10, Ioannis Hatzaras11, Rivfka Shenoy11, David A Kooby1, Shishir K Maithel1.   

Abstract

Importance: The current recommendation is to perform re-resection for select patients with incidentally discovered gallbladder cancer. The optimal time interval for re-resection for both patient selection and long-term survival is not known. Objective: To assess the association of time interval from the initial cholecystectomy to reoperation with overall survival. Design, Setting, and Participants: This cohort study was conducted from January 1, 2000, to December 31, 2014 at 10 US academic institutions. A total of 207 patients with incidentally discovered gallbladder cancer who underwent reoperation and had available data on the date of their initial cholecystectomy were included. Exposures: Time interval from the initial cholecystectomy to reoperation: group A: less than 4 weeks; group B: 4 to 8 weeks; and group C: greater than 8 weeks. Main Outcomes and Measures: Primary outcome was overall survival.
Results: Of 449 patients with gallbladder cancer, 207 cases (46%) were discovered incidentally and underwent reoperation at 3 different time intervals from the date of the original cholecystectomy: group A: less than 4 weeks (25 patients, 12%); B: 4 to 8 weeks (91 patients, 44%); C: more than 8 weeks (91 patients, 44%). The mean (SD) ages of patients in groups A, B, and C were 65 (9), 64 (11), and 66 (12) years, respectively. All groups were similar for baseline demographics, extent of resection, presence of residual disease, T stage, resection margin status, lymph node involvement, and postoperative complications. Patients who underwent reoperation between 4 and 8 weeks had the longest median overall survival (group B: 40.4 months) compared with those who underwent early (group A: 17.4 months) or late (group C: 22.4 months) reoperation (log-rank P = .03). Group A and C time intervals (vs group B), presence of residual disease, an R2 resection, advanced T stage, and lymph node involvement were associated with decreased overall survival on univariable Cox regression. Only group A (hazard ratio, 2.63; 95% CI, 1.25-5.54) and group C (hazard ratio, 2.07; 95% CI, 1.17-3.66) time intervals (vs group B), R2 resection (hazard ratio, 2.69; 95% CI, 1.27-5.69), and advanced Tstage (hazard ratio, 1.85; 95% CI, 1.11-3.08) persisted on multivariable Cox regression analysis. Conclusions and Relevance: The optimal time interval for re-resection for incidentally discovered gallbladder cancer appears to be between 4 and 8 weeks after the initial cholecystectomy.

Entities:  

Mesh:

Year:  2017        PMID: 27784058      PMCID: PMC5800764          DOI: 10.1001/jamasurg.2016.3642

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  14 in total

1.  Relevance of residual disease after liver resection for incidental gallbladder cancer.

Authors:  Javier C Lendoire; Luis Gil; Fernando Duek; Carlos Quarin; Verónica Garay; Gabriel Raffin; Marcelo Rivaldi; Oks Alejandra; Oscar Imventarza
Journal:  HPB (Oxford)       Date:  2012-06-08       Impact factor: 3.647

2.  Incidental gallbladder cancer: analysis of surgical findings and survival.

Authors:  Jean M Butte; Enrique Waugh; Manuel Meneses; Hugo Parada; Hernán A De La Fuente
Journal:  J Surg Oncol       Date:  2010-11-01       Impact factor: 3.454

3.  Gallbladder cancer: expert consensus statement.

Authors:  Thomas A Aloia; Nicolas Járufe; Milind Javle; Shishir K Maithel; Juan C Roa; Volkan Adsay; Felipe J F Coimbra; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

4.  The role of laparoscopic staging in patients with incidental gallbladder cancer.

Authors:  Jean M Butte; Mithat Gönen; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Yuman Fong; Ronald P Dematteo; Leslie Blumgart; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2011-06-07       Impact factor: 3.647

5.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

6.  Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research.

Authors:  S Benoist; Y Panis; P L Fagniez
Journal:  Am J Surg       Date:  1998-02       Impact factor: 2.565

7.  Incidental gallbladder cancer by the AFC-GBC-2009 Study Group.

Authors:  David Fuks; Jean Marc Regimbeau; Yves-Patrice Le Treut; Philippe Bachellier; Artivas Raventos; François-René Pruvot; Laurence Chiche; Olivier Farges
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 8.  Incidentally-discovered gallbladder cancer: When, why and which reoperation?

Authors:  M Isambert; C Leux; S Métairie; J Paineau
Journal:  J Visc Surg       Date:  2011-04-08       Impact factor: 2.043

9.  Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.

Authors:  Jan Franko; George Voynov; Charles D Goldman
Journal:  Ann Thorac Surg       Date:  2015-12-01       Impact factor: 4.330

10.  Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer.

Authors:  Jean M Butte; T Peter Kingham; Mithat Gönen; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P DeMatteo; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-05-16       Impact factor: 6.113

View more
  23 in total

Review 1.  The Landmark Series: Gallbladder Cancer.

Authors:  Adriana C Gamboa; Shishir K Maithel
Journal:  Ann Surg Oncol       Date:  2020-05-30       Impact factor: 5.344

2.  Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.

Authors:  Stefan Buettner; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Matthew Weiss; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Bas Groot Koerkamp; Shishir K Maithel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-14       Impact factor: 3.452

3.  Does Anatomic Resection Get More Benefits than Wedge Hepatectomy on the Prognosis for pT3 Unsuspected Gallbladder Cancer?

Authors:  Liang-He Yu; Bo Yuan; Xiao-Hui Fu; Wen-Long Yu; Jian Liu; Yong-Jie Zhang
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2019-08-12       Impact factor: 1.878

Review 4.  Evaluation and management of incidental gallbladder cancer.

Authors:  Mohammad Y Zaidi; Ghassan K Abou-Alfa; Cecilia G Ethun; Shailesh V Shrikhande; Mahesh Goel; Bruno Nervi; John Primrose; Juan W Valle; Shishir K Maithel
Journal:  Chin Clin Oncol       Date:  2019-08-05

5.  Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Cecilia G Ethun; Lauren M Postlewait; Nina Le; Timothy M Pawlik; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley A Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Kenneth Cardona; Shishir K Maithel
Journal:  J Surg Oncol       Date:  2017-02-23       Impact factor: 3.454

6.  Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group.

Authors:  Ryusei Matsuyama; Kenichi Matsuo; Ryutaro Mori; Mitsutaka Sugita; Naotaka Yamaguchi; Toru Kubota; Kunio Kameda; Yasuhisa Mochizuki; Ryo Takagawa; Toshiaki Kadokura; Goro Matsuda; Noriyuki Kamiya; Itaru Endo
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

7.  The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.

Authors:  Cecilia G Ethun; Alexandra G Lopez-Aguiar; Jeffery M Switchenko; Theresa W Gillespie; Keith A Delman; Charles A Staley; Shishir K Maithel; Kenneth Cardona
Journal:  Ann Surg Oncol       Date:  2019-09-09       Impact factor: 5.344

8.  Surgical strategy for suspected early gallbladder carcinoma including incidental gallbladder carcinoma diagnosed during or after cholecystectomy.

Authors:  Toshikatsu Nitta; Jun Kataoka; Masato Ohta; Kensuke Fujii; Yuko Takashima; Yoshihiro Inoue; Takashi Ishibashi
Journal:  Ann Med Surg (Lond)       Date:  2018-08-02

9.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

10.  Laparoscopic surgery for oncologic extended resection of T1b and T2 incidental gallbladder carcinoma at a high-volume center: a single-center experience in China.

Authors:  Parbatraj Regmi; Hai-Jie Hu; Yin Chang-Hao; Fei Liu; Wen-Jie Ma; Cong-Dun Ran; Jun-Ke Wang; Aliza Paudyal; Nan-Sheng Cheng; Fu-Yu Li
Journal:  Surg Endosc       Date:  2020-11-10       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.